Search

Your search keyword '"Hernández-Blasco, L."' showing total 318 results

Search Constraints

Start Over You searched for: "Hernández-Blasco, L." Remove constraint "Hernández-Blasco, L."
318 results on '"Hernández-Blasco, L."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

14. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

15. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

17. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

18. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

19. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

20. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

21. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

23. Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.

24. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

25. DVT Management and Outcome Trends, 2001 to 2014

26. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

27. Transcriptomic Profiling of Pleural Effusions: Differences in Malignant and Infectious Fluids.

28. Radiological usual interstitial pneumonia pattern is associated with two-year mortality in patients with idiopathic pulmonary fibrosis.

29. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

30. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

31. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

32. First evidence of microplastics isolated in European citizens' lower airway

33. Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data

35. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

36. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.

38. Comparison of Presentation, Treatment, and Outcomes of Venous Thromboembolism in Long-Term Immobile Patients Based on Age.

39. Timing and characteristics of venous thromboembolism after noncancer surgery

41. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

42. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

43. Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.

44. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

45. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

46. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).

47. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

48. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

49. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

50. Proangiogenic factor midkine is increased in melanoma patients with sleep apnea and induces tumor cell proliferation.

Catalog

Books, media, physical & digital resources